Nutrien Ltd. (TSE:NTR – Get Rating) has earned a consensus recommendation of “Moderate Buy” from the eight analysts that are presently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and five have assigned a buy recommendation to the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is C$103.14.
A number of equities research analysts have recently weighed in on NTR shares. Royal Bank of Canada lowered their target price on Nutrien from C$110.00 to C$100.00 and set an “outperform” rating for the company in a research note on Thursday, April 13th. Scotiabank upgraded Nutrien from a “sector perform” rating to a “sector outperform” rating in a report on Monday, April 10th.
Nutrien Trading Up 1.0 %
Shares of NTR stock opened at C$83.73 on Monday. The company has a quick ratio of 0.65, a current ratio of 1.14 and a debt-to-equity ratio of 46.12. The business has a 50-day moving average price of C$94.42 and a two-hundred day moving average price of C$100.95. Nutrien has a 12-month low of C$79.15 and a 12-month high of C$132.75. The firm has a market cap of C$41.54 billion, a P/E ratio of 4.78, a price-to-earnings-growth ratio of 0.36 and a beta of 0.89.
Nutrien Dividend Announcement
Nutrien Company Profile
Nutrien Ltd. provides crop inputs and services. It offers potash, nitrogen, phosphate, and sulfate products; and financial solutions. The company also distributes crop nutrients, crop protection products, seeds, and merchandise products through approximately 2,000 retail locations in the United States, Canada, South America, and Australia.
- MarketBeat Week in Review – 5/15 – 5/19
- Applied Materials: Cracks In The Chip Recovery Or Time To Buy?
- Deere & Company Rallies On Farm Equipment Boom, Bullish Outlook
- How Many Roth IRAs Can You Have?
- Why You Should Consider Buying Nvidia Ahead Of Earnings
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.